Galderma Group AG

F:PY30

Business Description

Sector

Health Care

Industry

Pharmaceuticals

Headquarters

Switzerland CH

Employees

7 676

IPO date

Mar 22, 2024

Galderma Group AG is a skin-health company that focuses on treatments and products for the skin, face, and body. It sells prescription dermatology medicines, injectable aesthetic treatments, and over-the-counter skin care products. Its portfolio includes products used by dermatologists, medical professionals, and consumers who want help with conditions such as acne, rosacea, eczema, and age-related skin concerns.

The company makes money by selling these products through healthcare channels, clinics, pharmacies, and consumer retail outlets, depending on the product type. Prescriptions and physician-administered treatments are aimed at medical practices and aesthetic clinics, while its skin care brands are sold more broadly to everyday shoppers. This gives Galderma a mix of professional, clinic-based, and consumer revenue streams.

What makes Galderma different is that it sits at the intersection of medicine and beauty. It is not just a drug maker or a cosmetics company; it focuses specifically on skin health and aesthetic dermatology, where treatment and appearance often overlap. That position gives it a clear role in the value chain for skin specialists, injectors, and consumers looking for trusted products backed by dermatology expertise.